FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating Disorder
The pharmaceutical company developing psilocybin-based compounds for diseases with unmet medical needs estimates a $2.9 billion market potential for such a treatment.
Day: December 23, 2021
Microdosing VS. Macrodosing Magic Mushrooms feat. Julianne Keu
In today’s interview with Julianne Keu, the famous Microdoser, discusses…
End of content
End of content